Effects of Atomoxetine in Mild Cognitive Impairment

NCT01522404 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment

Interventions

DRUG: Atomoxetine
DRUG: Placebo

Sponsor

Emory University

Collaborators

[object Object]